133 related articles for article (PubMed ID: 30201337)
1. Hyperoside and let-7a-5p synergistically inhibits lung cancer cell proliferation via inducing G1/S phase arrest.
Li JP; Liao XH; Xiang Y; Yao A; Song RH; Zhang ZJ; Huang F; Dai ZT; Zhang TC
Gene; 2018 Dec; 679():232-240. PubMed ID: 30201337
[TBL] [Abstract][Full Text] [Related]
2. The preventive effects of hyperoside on lung cancer in vitro by inducing apoptosis and inhibiting proliferation through Caspase-3 and P53 signaling pathway.
Liu YH; Liu GH; Mei JJ; Wang J
Biomed Pharmacother; 2016 Oct; 83():381-391. PubMed ID: 27419887
[TBL] [Abstract][Full Text] [Related]
3. The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance.
Gong J; He L; Ma J; Zhang J; Wang L; Wang J
J BUON; 2017; 22(2):454-461. PubMed ID: 28534369
[TBL] [Abstract][Full Text] [Related]
4. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of hyperoside on lung cancer by inducing apoptosis and suppressing inflammatory response via caspase-3 and NF-κB signaling pathway.
Lü P
Biomed Pharmacother; 2016 Aug; 82():216-25. PubMed ID: 27470358
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1.
Gu H; Yang T; Fu S; Chen X; Guo L; Ni Y
Biochem Biophys Res Commun; 2014 Jan; 444(1):104-8. PubMed ID: 24440705
[TBL] [Abstract][Full Text] [Related]
8. Hyperoside induces both autophagy and apoptosis in non-small cell lung cancer cells in vitro.
Fu T; Wang L; Jin XN; Sui HJ; Liu Z; Jin Y
Acta Pharmacol Sin; 2016 Apr; 37(4):505-18. PubMed ID: 26948085
[TBL] [Abstract][Full Text] [Related]
9. Investigating the role of let-7a microRNA in cisplatin sensitivity of A549 lung cancer cells.
Aslan ES; Aydin E
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3979-3984. PubMed ID: 37991541
[TBL] [Abstract][Full Text] [Related]
10. Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.
He X; Duan C; Chen J; Ou-Yang X; Zhang Z; Li C; Peng H
FEBS Lett; 2009 Nov; 583(21):3501-7. PubMed ID: 19818775
[TBL] [Abstract][Full Text] [Related]
11. Integrated microRNA and gene expression profiling reveals the crucial miRNAs in curcumin anti-lung cancer cell invasion.
Zhan JW; Jiao DM; Wang Y; Song J; Wu JH; Wu LJ; Chen QY; Ma SL
Thorac Cancer; 2017 Sep; 8(5):461-470. PubMed ID: 28660665
[TBL] [Abstract][Full Text] [Related]
12. Let-7c inhibits NSCLC cell proliferation by targeting HOXA1.
Zhan M; Qu Q; Wang G; Liu YZ; Tan SL; Lou XY; Yu J; Zhou HH
Asian Pac J Cancer Prev; 2013; 14(1):387-92. PubMed ID: 23534758
[TBL] [Abstract][Full Text] [Related]
13. Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.
Shao Y; Shen YQ; Li YL; Liang C; Zhang BJ; Lu SD; He YY; Wang P; Sun QL; Jin YX; Ma ZL
Oncotarget; 2016 Jun; 7(23):34011-21. PubMed ID: 27049724
[TBL] [Abstract][Full Text] [Related]
14. MiR-509-3-5p causes aberrant mitosis and anti-proliferative effect by suppression of PLK1 in human lung cancer A549 cells.
Wang XH; Lu Y; Liang JJ; Cao JX; Jin YQ; An GS; Ni JH; Jia HT; Li SY
Biochem Biophys Res Commun; 2016 Sep; 478(2):676-82. PubMed ID: 27498003
[TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
Jin H; Qiao F; Wang Y; Xu Y; Shang Y
Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
[TBL] [Abstract][Full Text] [Related]
16. Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
Shi Y; Zhang Y; Ran F; Liu J; Lin J; Hao X; Ding L; Ye Q
Cancer Lett; 2020 Dec; 495():53-65. PubMed ID: 32946964
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression.
Wang YY; Ren T; Cai YY; He XY
Cancer Biother Radiopharm; 2013 Mar; 28(2):131-7. PubMed ID: 23134218
[TBL] [Abstract][Full Text] [Related]
18. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis.
Qi L; Liu F; Zhang F; Zhang S; Lv L; Bi Y; Yu Y
Biomed Pharmacother; 2018 Jul; 103():1507-1515. PubMed ID: 29864936
[TBL] [Abstract][Full Text] [Related]
19. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
20. Hyperoside exhibits anticancer activity in non‑small cell lung cancer cells with T790M mutations by upregulating FoxO1 via CCAT1.
Hu Z; Zhao P; Xu H
Oncol Rep; 2020 Feb; 43(2):617-624. PubMed ID: 31894285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
